• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的临床研究。I. 来自哥德堡的发病率资料介绍。

Clinical studies on multiple sclerosis. I. Presentation of an incidence material from Gothenburg.

作者信息

Broman T, Andersen O, Bergmann L

出版信息

Acta Neurol Scand. 1981 Jan;63(1):6-33.

PMID:7468161
Abstract

Probable and possible MS cases with a debut during the years 1950-1964 within the city of Gothenburg were identified (312 cases). This corresponds to an incidence of 5.3 per 100,000. The material was stratified according to diagnostic probability into three categories. For the final analysis cases with the lowest diagnostic probability were omitted (about 9%). The follow-up was completed during 1977, i.e. 13-27 years from onset. A longitudinal analysis of each case was based upon a mixed prospective/retrospective study in which the authors personally examined the majority of the cases during most of the years. The female/male ratio was 1.5-1.6. The mortality rate was higher for males due in part to an earlier progressive development of multiple sclerosis and in part to a higher trend for acquisition of other mortal diseases. Bouts, as the first manifestation of the disease, were more frequent in young ages than in old, and more frequent among females than in males. The averages bout frequency decreased significantly with the duration of the disease as well as with the age of onset. The opposite trend was characteristic for development of a progressive course. Among symptoms at onset, those indicating lesions of long sensory and/or motor tracts (particularly the sensory) dominated. Such initial symptoms were seen in 30-40% of the younger patients and 70% of the older patients. The rest was divided between cases with optic nerve lesions (20-30% among younger, 12-15% among older patients) and brain stem lesions (approx. 25% among younger, 10-19% among older patients). The occurrence of various symptoms during the first two decades of the disease was also analyzed and the pattern of symptoms presented graphically. These results will be treated further in subsequent studies.

摘要

确定了1950年至1964年间首次发病于哥德堡市的可能和疑似多发性硬化症病例(312例)。这相当于每10万人中有5.3例的发病率。根据诊断可能性将资料分为三类。在最终分析中,剔除了诊断可能性最低的病例(约9%)。随访于1977年完成,即发病后13至27年。对每个病例的纵向分析基于一项混合前瞻性/回顾性研究,在大部分年份中,作者亲自检查了大多数病例。女性/男性比例为1.5至1.6。男性的死亡率较高,部分原因是多发性硬化症的进展较早,部分原因是患其他致命疾病的趋势较高。作为该疾病的首发表现,发作在年轻人中比在老年人中更频繁,在女性中比在男性中更频繁。平均发作频率随着疾病持续时间和发病年龄的增加而显著降低。疾病进展为进行性病程则呈现相反的趋势。在首发症状中,提示长感觉和/或运动束(尤其是感觉束)病变的症状占主导。此类初始症状在年轻患者中占30%至40%,在老年患者中占70%。其余患者分为视神经病变(年轻患者中占20%至30%,老年患者中占12%至15%)和脑干病变(年轻患者中约占25%,老年患者中占10%至19%)。还分析了疾病最初二十年中各种症状的发生情况,并以图表形式呈现症状模式。这些结果将在后续研究中进一步探讨。

相似文献

1
Clinical studies on multiple sclerosis. I. Presentation of an incidence material from Gothenburg.多发性硬化症的临床研究。I. 来自哥德堡的发病率资料介绍。
Acta Neurol Scand. 1981 Jan;63(1):6-33.
2
[Late onset multiple sclerosis].[迟发性多发性硬化症]
Rev Neurol (Paris). 2002 Nov;158(11):1082-7.
3
[Clinical analysis of 70 neuropathologic cases of multiple sclerosis].70例多发性硬化神经病理学病例的临床分析
Rev Neurol (Paris). 1985;141(8-9):546-52.
4
Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.复发性视神经脊髓炎的临床特征、病程及预后
J Neurol. 2004 Jan;251(1):47-52. doi: 10.1007/s00415-004-0271-0.
5
[Survival in amyotrophic lateral sclerosis].[肌萎缩侧索硬化症的生存情况]
Srp Arh Celok Lek. 1997 Jan-Feb;125(1-2):19-23.
6
Multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕的多发性硬化症
Int Rev Neurobiol. 2007;79:357-75. doi: 10.1016/S0074-7742(07)79016-5.
7
Natural history of multiple sclerosis: a unifying concept.多发性硬化症的自然史:一个统一的概念。
Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16.
8
Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?伊拉克的多发性硬化症:它具有西方国家所遇到的相同特征吗?
J Neurol Sci. 2005 Jul 15;234(1-2):67-71. doi: 10.1016/j.jns.2005.03.033.
9
Is late-onset multiple sclerosis associated with a worse outcome?迟发性多发性硬化症是否与更差的预后相关?
Neurology. 2006 Sep 26;67(6):954-9. doi: 10.1212/01.wnl.0000237475.01655.9d.
10
[Clinical-epidemiological characteristics of late onset multiple sclerosis].[迟发性多发性硬化的临床流行病学特征]
Rev Neurol. 1997 Dec;25(148):1863-6.

引用本文的文献

1
Predictive factors and treatment challenges in malignant progression of relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症恶性进展的预测因素及治疗挑战
Heliyon. 2024 Feb 17;10(4):e26658. doi: 10.1016/j.heliyon.2024.e26658. eCollection 2024 Feb 29.
2
Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.进展性多发性硬化症患者的细胞因子谱及其与疾病进展和残疾的关系。
Mol Neurobiol. 2017 May;54(4):2950-2960. doi: 10.1007/s12035-016-9846-x. Epub 2016 Mar 29.
3
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
多发性硬化症的结果谱:残疾、死亡率以及一组起病时的预测因素。
J Neurol. 2015 May;262(5):1148-63. doi: 10.1007/s00415-015-7674-y. Epub 2015 Feb 26.
4
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.在西班牙,注射用疾病修正疗法治疗复发型多发性硬化症的成本效益分析。
Eur J Health Econ. 2014 May;15(4):353-62. doi: 10.1007/s10198-013-0478-z. Epub 2013 Apr 25.
5
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.多发性硬化症的自然病史:基于地理的研究 10:复发和长期残疾。
Brain. 2010 Jul;133(Pt 7):1914-29. doi: 10.1093/brain/awq118. Epub 2010 Jun 9.
6
Clinical prognostic factors in multiple sclerosis: a natural history review.多发性硬化症的临床预后因素:自然病史回顾。
Nat Rev Neurol. 2009 Dec;5(12):672-82. doi: 10.1038/nrneurol.2009.178.
7
Quantitative risk-benefit analysis of natalizumab.那他珠单抗的定量风险效益分析。
Neurology. 2008 Jul 29;71(5):357-64. doi: 10.1212/01.wnl.0000319648.65173.7a.
8
Immunologic therapy for relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症的免疫治疗
Curr Neurol Neurosci Rep. 2001 May;1(3):277-85. doi: 10.1007/s11910-001-0031-9.
9
Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.多发性硬化症中脑和脊髓萎缩的三维磁共振成像估计
J Neurol Neurosurg Psychiatry. 1999 Mar;66(3):323-30. doi: 10.1136/jnnp.66.3.323.
10
Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.阿昔洛韦治疗复发缓解型多发性硬化症。一项随机、安慰剂对照、双盲研究。
J Neurol. 1996 Mar;243(3):214-24. doi: 10.1007/BF00868517.